secwatch.observer — SEC 8-K summary
======================================

Issuer:     SURMODICS INC (—)
CIK:        0000924717
Form:       8-K
Filed at:   2025-11-19T23:59:59+00:00
Accession:  0001193125-25-288169
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.02, 2.01, 3.01, 3.03, 5.03, 5.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surmodics acquired by GTCR-backed BCE Parent for $43.00/share; stock to be delisted
--------------------------------------------------------------------------------

- Completion of merger on November 19, 2025; each share of common stock converted into $43.00 cash.
- Nasdaq halt on Nov 18, delisting and deregistration of SRDX requested; Form 15 to be filed.
- Credit, Security and Guaranty Agreement with MidCap and related swap with Wells Fargo terminated.
- All prior directors and officers replaced; Robert B. Hance appointed President/CEO, Scott D’Amour CFO.
- Merger funded by GTCR equity and debt from Oak Hill Advisors, BMO, Antares, Brinley, Northwestern Mutual.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/924717/000119312525288169/0001193125-25-288169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/924717/000119312525288169/d864112d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-288169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer